Compare LECO & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LECO | WST |
|---|---|---|
| Founded | 1895 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 18.5B |
| IPO Year | 1994 | 2004 |
| Metric | LECO | WST |
|---|---|---|
| Price | $257.89 | $257.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $273.67 | ★ $319.43 |
| AVG Volume (30 Days) | 336.3K | ★ 780.5K |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.23% | 0.34% |
| EPS Growth | ★ 14.36 | 1.49 |
| EPS | ★ 9.32 | 6.79 |
| Revenue | ★ $3,761,211,000.00 | $2,886,900,000.00 |
| Revenue This Year | $8.65 | $6.76 |
| Revenue Next Year | $5.28 | $6.25 |
| P/E Ratio | ★ $27.50 | $37.80 |
| Revenue Growth | ★ 16.30 | 1.95 |
| 52 Week Low | $169.69 | $193.05 |
| 52 Week High | $310.00 | $322.34 |
| Indicator | LECO | WST |
|---|---|---|
| Relative Strength Index (RSI) | 51.31 | 57.75 |
| Support Level | $253.07 | $253.53 |
| Resistance Level | $264.87 | $261.98 |
| Average True Range (ATR) | 6.79 | 7.14 |
| MACD | 1.86 | 1.33 |
| Stochastic Oscillator | 90.14 | 66.90 |
Lincoln Electric is a leading manufacturer of welding, cutting, and brazing products. Its portfolio includes arc-welding solutions, plasma and oxy-fuel cutting systems, brazing and soldering alloys, and automation solutions. Lincoln Electric serves clients across general fabrication, heavy industries, automotive, construction, shipbuilding, energy, and process industries, among others. Based in Cleveland, Lincoln Electric operates in 19 countries and employs 11,000 worldwide. The company generated roughly $4.2 billion in sales in 2025.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.